Immunome Inc. IMNM
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-10-02
Immunome Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Rosett Max | Chief Financial Officer | 2026-06-15 | Option exercise | 60,000 | $1.05 |
| Rosett Max | Chief Financial Officer | 2026-06-15 | Sell | 60,000 | $18.23 |
| BIENAIME JEAN JACQUES | director | 2026-06-05 | Sell | 500 | $19.44 |
| BIENAIME JEAN JACQUES | director | 2026-06-05 | Sell | 10,000 | $19.41 |
| BIENAIME JEAN JACQUES | director | 2026-06-05 | Buy | 6,000 | $19.48 |
| BIENAIME JEAN JACQUES | director | 2026-06-05 | Buy | 3,500 | $19.46 |
| BIENAIME JEAN JACQUES | director | 2026-06-05 | Buy | 1,000 | $19.27 |
| BIENAIME JEAN JACQUES | director | 2026-05-15 | Buy | 5,000 | $20.70 |
Source: SEC EDGAR filings · CIK 0001472012 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.